ArticleFrontiers in pharmacology2019
Long-Term Retention Rate of Anakinra in Adult Onset Still's Disease and Predictive Factors for Treatment Response.
Open access · goldAbstract read
In one paragraph
Article in Frontiers in pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 40 citations in OpenAlex.
- Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial.Annals of the rheumatic diseases · 2020Trial
- Review
- Structural and dynamic properties of IL1 receptors.Frontiers in immunology · 2025Review
- Disease activity score for still's disease.Clinical rheumatology · 2024Article
- Still's Disease Onset in Older Adults: Clinical Features, Diagnosis, and Management.Drugs & aging · 2024Review
- Risk of Macrophage Activation Syndrome in Patients with Adult-Onset Still's Disease Treated with IL-1 and IL-6 Inhibitors: A Meta-analysis and Single-Center Experience.Rheumatology and therapy · 2023Article
- Diagnosis and treatment of adult-onset Still's disease: a concise summary of the German society of rheumatology S2 guideline.Zeitschrift fur Rheumatologie · 2023Review
- Canakinumab as first-line biological therapy in Still's disease and differences between the systemic and the chronic-articular courses: Real-life experience from the international AIDA registry.Frontiers in medicine · 2022Article
- Adult-onset Still's disease: A disease at the crossroad of innate immunity and autoimmunity.Frontiers in medicine · 2022Review
- A case of adult-onset Still's disease accompanied with pulmonary tuberculosis successfully treated with colchicine.Postepy dermatologii i alergologii · 2021Article
- Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations.Scientific reports · 2020Article
- Autoinflammatory Pathogenesis and Targeted Therapy for Adult-Onset Still's Disease.Clinical reviews in allergy & immunology · 2020Review
- Real-Life Data on the Efficacy of Canakinumab in Patients with Adult-Onset Still's Disease.Mediators of inflammation · 2020Article
- Interleukin-1 Blockade in Polygenic Autoinflammatory Disorders: Where Are We now?Frontiers in pharmacology · 2020Review
- Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes.Frontiers in medicine · 2020Article
- Article
- Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease.Frontiers in pharmacology · 2019Article
- Editorial: New Therapies in the Field of Rheumatology.Frontiers in pharmacology · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
48 authors at 17 institutions in 1 country.
Antonio VitaleResearch Centre of Systemic Autoinflammatory Diseases, Behçet's Disease Clinic and Rheumatology-Ophthalmology Collaborative Uveitis Centre, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena, Italy.
Giulio CavalliVita-Salute San Raffaele University, Milan, Italy.
Serena ColafrancescoRheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Rome, Italy.
Roberta PrioriRheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Rome, Italy.
Guido ValesiniRheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Rome, Italy.
Lorenza Maria ArgoliniDivision of Rheumatology, ASST Gaetano Pini, Milan, Italy.
Elena BaldisseraUnit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Scientific Institute, Milan, Italy.
Elena BartoloniRheumatology Unit, Department of Medicine, University of Perugia, Perugia, Italy.
Daniele CammelliDepartment of Experimental and Clinical Medicine, University of Firenze, Firenze, Italy.
Giovanni CanestrariInstitute of Rheumatology and Affine Sciences, Division of Rheumatology, Catholic University of the Sacred Heart, Rome, Italy.
Jurgen SotaResearch Centre of Systemic Autoinflammatory Diseases, Behçet's Disease Clinic and Rheumatology-Ophthalmology Collaborative Uveitis Centre, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena, Italy.
Elena CavallaroDepartment of Medical and Biological Sciences, Rheumatology Clinic, University of Udine, Udine, Italy.
Maria Grazia MassaroPeriodic Fever Research Center, Institute of Internal Medicine, Catholic University of the Sacred Heart, Fondazione Policlinico A. Gemelli, Rome, Italy.
Piero RuscittiDepartment of Biotechnological and Applied Clinical Science, Division of Rheumatology, University of L'Aquila, L'Aquila, Italy.
Paola CiprianiDepartment of Biotechnological and Applied Clinical Science, Division of Rheumatology, University of L'Aquila, L'Aquila, Italy.
Ginevra De MarchiDepartment of Medical and Biological Sciences, Rheumatology Clinic, University of Udine, Udine, Italy.
Salvatore De VitaDepartment of Medical and Biological Sciences, Rheumatology Clinic, University of Udine, Udine, Italy.
Giacomo EmmiDepartment of Experimental and Clinical Medicine, University of Firenze, Firenze, Italy.
Gianfranco FerraccioliInstitute of Rheumatology and Affine Sciences, Division of Rheumatology, Catholic University of the Sacred Heart, Rome, Italy.
Micol FrassiRheumatology and Clinical Immunology, Spedali Civili and Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Roberto GerliRheumatology Unit, Department of Medicine, University of Perugia, Perugia, Italy.
Elisa GremeseInstitute of Rheumatology and Affine Sciences, Division of Rheumatology, Catholic University of the Sacred Heart, Rome, Italy.
Florenzo IannoneRheumatology Unit, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy.
Giovanni LapadulaRheumatology Unit, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy.
Giuseppe LopalcoRheumatology Unit, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy.
Raffaele MannaPeriodic Fever Research Center, Institute of Internal Medicine, Catholic University of the Sacred Heart, Fondazione Policlinico A. Gemelli, Rome, Italy.
Alessandro MathieuRheumatology Unit, Department of Medical Sciences, University and AOU of Cagliari, Cagliari, Italy.
Carlomaurizio MontecuccoDepartment of Rheumatology, IRCCS Policlinico San Matteo Foundation, University of Pavia, Pavia, Italy.
Marta MoscaRheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Ilaria PiazzaRheumatology Unit, Department of Medicine, University of Verona, Verona, Italy.
Matteo PigaRheumatology Unit, Department of Medical Sciences, University and AOU of Cagliari, Cagliari, Italy.
Irene PontikakiDivision of Rheumatology, ASST Gaetano Pini, Milan, Italy.
Micol RomanoDivision of Rheumatology, ASST Gaetano Pini, Milan, Italy.
Silvia RossiDepartment of Rheumatology, IRCCS Policlinico San Matteo Foundation, University of Pavia, Pavia, Italy.
Maurizio RossiniRheumatology Unit, Department of Medicine, University of Verona, Verona, Italy.
Elena SilvestriDepartment of Experimental and Clinical Medicine, University of Firenze, Firenze, Italy.
Chiara StagnaroRheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Rosaria TalaricoRheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Angela TincaniRheumatology and Clinical Immunology, Spedali Civili and Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Ombretta ViapianaRheumatology Unit, Department of Medicine, University of Verona, Verona, Italy.
Gianfranco VitielloDepartment of Experimental and Clinical Medicine, University of Firenze, Firenze, Italy.
Paola GalozziDepartment of Medicine DIMED, Rheumatology Unit, University of Padua, Padua, Italy.
Paolo SfrisoDepartment of Medicine DIMED, Rheumatology Unit, University of Padua, Padua, Italy.
Carla GaggianoClinical Pediatrics, Department of Molecular Medicine and Development, University of Siena, Siena, Italy.
Donato RiganteInstitute of Pediatrics, Università Cattolica Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli I.R.C.C.S., Rome, Italy.
Lorenzo DagnaVita-Salute San Raffaele University, Milan, Italy.
Roberto GiacomelliDepartment of Biotechnological and Applied Clinical Science, Division of Rheumatology, University of L'Aquila, L'Aquila, Italy.
Luca CantariniResearch Centre of Systemic Autoinflammatory Diseases, Behçet's Disease Clinic and Rheumatology-Ophthalmology Collaborative Uveitis Centre, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena, Italy.
Università Cattolica del Sacro Cuore · ITUniversity of Florence · ITUniversity of Siena · ITIstituto Ortopedico Gaetano Pini · ITSapienza University of Rome · ITUniversity of Bari Aldo Moro · ITUniversity of L'Aquila · ITUniversity of Pisa · ITUniversity of Udine · ITUniversity of Verona · ITUniversity of Brescia · ITUniversity of Cagliari · ITUniversity of Padua · ITUniversity of Pavia · ITUniversity of Perugia · ITVita-Salute San Raffaele University · ITIstituto di Ricovero e Cura a Carattere Scientifico San Raffaele
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
autoinflammatory diseasescanakinumabinnovative biotechnologiesinterleukin-1personalized medicinesystemic onset juvenile idiopathic arthritis
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.